These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33687063)

  • 41. Radioactive iodine therapy.
    Lee SL
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):420-8. PubMed ID: 22914564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach.
    Dorn R; Kopp J; Vogt H; Heidenreich P; Carroll RG; Gulec SA
    J Nucl Med; 2003 Mar; 44(3):451-6. PubMed ID: 12621014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer.
    Kim SK; Yun GY; Kim KH; Park SK; Choi HY; Ha SK; Park HC
    Thyroid; 2014 Apr; 24(4):773-7. PubMed ID: 24093878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radioactive iodine ablation post differentiated thyroid cancer surgery: an analysis of use and impact of the American Thyroid Association guidelines.
    Sia Y; Dave RV; Nour D; Miller JA; Skandarajah AR; Tasevski R
    ANZ J Surg; 2019 Nov; 89(11):E502-E506. PubMed ID: 31674140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan M; Perkins JM; Roman SA; Sosa JA
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1529-36. PubMed ID: 25642591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.
    Liu X; Fan Y; Liu Y; He X; Zheng X; Tan J; Jia Q; Meng Z
    Updates Surg; 2020 Sep; 72(3):871-884. PubMed ID: 32342347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy.
    Lee JE; Kim SK; Han KH; Cho MO; Yun GY; Kim KH; Choi HY; Ryu YH; Ha SK; Park HC
    PLoS One; 2014; 9(8):e106840. PubMed ID: 25170831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of radioactive iodine treatment in differentiated thyroid cancer and cardiovascular death: a large population-based study.
    Zhang H; Xie H; Li L
    J Endocrinol Invest; 2024 Feb; 47(2):443-453. PubMed ID: 37543985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative radioactive iodine-131 ablation is not necessary among patients with intermediate-risk differentiated thyroid carcinoma: a population-based study.
    Zhang H; Cai Y; Zheng L; Zhang Z; Jiang N
    Hell J Nucl Med; 2017; 20(1):3-10. PubMed ID: 28315902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas.
    Esfandiari NH; Hughes DT; Reyes-Gastelum D; Ward KC; Hamilton AS; Haymart MR
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6060-6068. PubMed ID: 31415089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radioactive Iodine Therapy in Patients With Thyroid Carcinoma With Distant Metastases: A SEER-Based Study.
    Li C; Wu Q; Sun S
    Cancer Control; 2020; 27(1):1073274820914661. PubMed ID: 32292051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?
    Goffredo P; Roman SA; Sosa JA
    Thyroid; 2014 Mar; 24(3):463-71. PubMed ID: 23978295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
    Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physician Specialties Involved in Thyroid Cancer Diagnosis and Treatment: Implications for Improving Health Care Disparities.
    Radhakrishnan A; Reyes-Gastelum D; Abrahamse P; Gay B; Hawley ST; Wallner LP; Chen DW; Hamilton AS; Ward KC; Haymart MR
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1096-e1105. PubMed ID: 34718629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
    Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
    Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parathyroid changes after high dose radioactive iodine in patients with thyroid cancer.
    Guven A; Salman S; Boztepe H; Yarman S; Tanakol R; Azizlerli H; Alagol F
    Ann Nucl Med; 2009 Jul; 23(5):437-41. PubMed ID: 19455388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival.
    Boucai L; Falcone J; Ukena J; Coombs CC; Zehir A; Ptashkin R; Berger MF; Levine RL; Fagin JA
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4216-4223. PubMed ID: 30137527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
    Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
    J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Ovarian Reserve with AMH Level in Patients with Well-Differentiated Thyroid Cancer Receiving Radioactive Iodine Ablation Treatment.
    Acıbucu F; Acıbucu DO; Akkar ÖB; Dokmetas HS
    Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):593-596. PubMed ID: 27711957
    [No Abstract]   [Full Text] [Related]  

  • 60. Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid.
    Podnos YD; Smith D; Wagman LD; Ellenhorn JD
    Surgery; 2005 Dec; 138(6):1072-6; discussion 1076-7. PubMed ID: 16360393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.